Publicacions en col·laboració amb investigadors/es de GlaxoSmithKline (United Kingdom) (7)

2016

  1. Sorting the good from the bad: The different approaches to predict cognitive properties of new symptomatic drug candidates for neurodegenerative diseases in early development

    CNS and Neurological Disorders - Drug Targets

2015

  1. Cognitive Impairment After Sleep Deprivation Rescued by Transcranial Magnetic Stimulation Application in Octodon degus

    Neurotoxicity Research, Vol. 28, Núm. 4, pp. 361-371

  2. Transcranial magnetic stimulation and aging: Effects on spatial learning and memory after sleep deprivation in Octodon degus

    Neurobiology of Learning and Memory, Vol. 125, pp. 274-281

2014

  1. Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus

    Neuropharmacology, Vol. 85, pp. 206-214

2013

  1. Effects of pharmacological agents, sleep deprivation, Hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: Towards translational challenge models for drug discovery in Alzheimer's disease

    Clinical Neurophysiology, Vol. 124, Núm. 3, pp. 437-451

  2. Evaluation of symptomatic drug effects in Alzheimer's disease: Strategies for prediction of efficacy in humans

    Drug Discovery Today: Technologies, Vol. 10, Núm. 3

  3. Octodon degus: A model for the cognitive impairment associated with alzheimer's disease

    CNS Neuroscience and Therapeutics, Vol. 19, Núm. 9, pp. 643-648